JPS6360040B2 - - Google Patents
Info
- Publication number
- JPS6360040B2 JPS6360040B2 JP62128684A JP12868487A JPS6360040B2 JP S6360040 B2 JPS6360040 B2 JP S6360040B2 JP 62128684 A JP62128684 A JP 62128684A JP 12868487 A JP12868487 A JP 12868487A JP S6360040 B2 JPS6360040 B2 JP S6360040B2
- Authority
- JP
- Japan
- Prior art keywords
- add
- solvent
- distilled
- ether
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 32
- 125000001185 polyprenyl group Polymers 0.000 claims description 10
- 229920001550 polyprenyl Polymers 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 78
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 54
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 38
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 239000002904 solvent Substances 0.000 description 29
- 238000003756 stirring Methods 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- QOSSAOTZNIDXMA-UHFFFAOYSA-N N,N′-Dicyclohexylcarbodiimide Substances C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N n-hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- -1 t-Butoxycarbonyl Chemical group 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 235000018417 cysteine Nutrition 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000009791 Tremellomycetes Species 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- UOCJDOLVGGIYIQ-PBFPGSCMSA-N cefatrizine Chemical group S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)[C@H](N)C=2C=CC(O)=CC=2)CC=1CSC=1C=NNN=1 UOCJDOLVGGIYIQ-PBFPGSCMSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 description 1
- LLHOYOCAAURYRL-RITPCOANSA-N (2s,3r)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)OC(C)(C)C LLHOYOCAAURYRL-RITPCOANSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- MWOOKDULMBMMPN-UHFFFAOYSA-N 3-(2-ethyl-1,2-oxazol-2-ium-5-yl)benzenesulfonate Chemical compound O1[N+](CC)=CC=C1C1=CC=CC(S([O-])(=O)=O)=C1 MWOOKDULMBMMPN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- FYYSQDHBALBGHX-YFKPBYRVSA-N N(alpha)-t-butoxycarbonyl-L-asparagine Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC(N)=O FYYSQDHBALBGHX-YFKPBYRVSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- NFVNYBJCJGKVQK-ZDUSSCGKSA-N N-[(Tert-butoxy)carbonyl]-L-tryptophan Chemical compound C1=CC=C2C(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CNC2=C1 NFVNYBJCJGKVQK-ZDUSSCGKSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000221427 Tremella mesenterica Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000005076 adamantyloxycarbonyl group Chemical group C12(CC3CC(CC(C1)C3)C2)OC(=O)* 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- TZPOCDBWQWIDSX-JQWIXIFHSA-N benzyl (2s,3s)-2-amino-3-methylpentanoate Chemical compound CC[C@H](C)[C@H](N)C(=O)OCC1=CC=CC=C1 TZPOCDBWQWIDSX-JQWIXIFHSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical class O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】
本発明は酵母の接合管形成促進作用を有する新
規S―ポリプレニルペプチド類に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel S-polyprenyl peptides that have the effect of promoting mating tube formation in yeast.
異担子菌酵母に属する Rhodosporidium
toruloidesやTremella mesentericaが、その生
活史で一倍体酵母から二倍体にうつる過程でホル
モン様物質が分泌され、その物質の誘導によつて
接合管をのばして細胞融合をおこすことはよく知
られている酵母の生理的現象である。この物質が
ペプチドであることは、その活性物質の探索から
明らかとなつて来たが、単純ペプチド、例えばH
―Tyr―Pro―Glu―Ile―Ser―Trp―Thr―Arg
―Asn―Gly―Cys―OHやH―Glu―His―Asp―
Pro―Ser―Ala―Pro―Gly―Asn―Gly―Tyr―
Cys―OHのような、その構造がホルモン様物質
と関連があると考えられるペプチド類には全く生
理作用が認められない。この事実は単純ペプチド
では異担子菌類酵母に作用を示さないことを示し
ている。若し、これら酵母に作用を示す物質が得
られるならば、酵母の育種、種の改良等に有効に
利用できるばかりでなく、また生化学、分子生化
学研究の重要な試薬ともなりうるものである。 Rhodosporidium, which belongs to the heterobasidiomycete yeast
It is well known that during the life history of toruloides and Tremella mesenterica, a hormone-like substance is secreted during the transition from haploid yeast to diploid yeast, and by the induction of this substance, they elongate the mating tube and cause cell fusion. This is a physiological phenomenon of yeast. It has become clear from the search for its active substance that this substance is a peptide, but simple peptides such as H
―Tyr―Pro―Glu―Ile―Ser―Trp―Thr―Arg
-Asn-Gly-Cys-OH and H-Glu-His-Asp-
Pro―Ser―Ala―Pro―Gly―Asn―Gly―Tyr―
Peptides such as Cys-OH, whose structure is thought to be related to hormone-like substances, have no physiological effects at all. This fact indicates that simple peptides have no effect on heterobasidiomycete yeast. If substances that act on these yeasts can be obtained, they can not only be used effectively for yeast breeding and seed improvement, but also serve as important reagents for biochemistry and molecular biochemistry research. be.
本発明者らは、これら活性物質に脂溶性残基が
結合しているとの推定のもとに、各種の脂溶性残
基をシステインの―SH基に導入して探索した結
果、S―ポリプレニルペプチド類において天然品
より強力な接合管形成促進作用を見い出し、本発
明を完成したものである。 Based on the assumption that fat-soluble residues are bound to these active substances, the present inventors investigated by introducing various fat-soluble residues into the -SH group of cysteine. The present invention was completed by discovering that prenyl peptides have a stronger effect on promoting junctional tube formation than natural products.
すなわち本発明は、
式
[式中、XはH―Tyr―Pro―Glu―Ile―Ser―
Trp―Thr―Arg―Asn―Gly―で表わされるペプ
チド鎖を示す]で表わされるS―ポリプレニルペ
プチドに関するものである。 That is, the present invention has the following formula: [In the formula, X is H-Tyr-Pro-Glu-Ile-Ser-
The present invention relates to an S-polyprenyl peptide represented by a peptide chain represented by Trp-Thr-Arg-Asn-Gly.
上記一般式()に関し、Yは場合によりアミ
ド化(無置換アミド)またはメチル、エチル、プ
ロピルなどの低級アルキル基でエステル化されて
いてもよいカルボキシル基を表わす。本明細書に
おいてアミノ酸もしくはその残基、ペプチド、保
護基、使用試薬等はIUPAC―IUBの命名委員会
で採用された略号または当該分野において慣用さ
れている略号が用いられることがあり、かかる略
号としてはたとえば下記の略号があげられる。 Regarding the above general formula (), Y represents a carboxyl group which may optionally be amidated (unsubstituted amide) or esterified with a lower alkyl group such as methyl, ethyl, propyl. In this specification, the abbreviations adopted by the IUPAC-IUB nomenclature committee or the abbreviations commonly used in the field may be used for amino acids or their residues, peptides, protecting groups, reagents used, etc. For example, the following abbreviations are given.
Ala:アラニン
Arg:アルギニン
Asn:アスパラギン
Asp:アスパラギン酸
Cys:システイン
Clu:グルタミン酸
Gly:グリシン
His:ヒスチジン
Ile:イソロイシン
Pro:プロリン
Ser:セリン
Thr:スレオニン
Trp:トリプトフアン
Tyr:チロシン
Boc:t―ブトキシカルボニル
Aoc:アミルオキシカルボニル
But:t―ブチル
Z:ベンジルオキシカルボニル
Me:メチル
Bzl:ベンジル
Bzl(Cl):p―クロルベンジル
MBzl:p―メトキシベンジル
Tos:トシル
DCC:N,N′―ジシクロヘキシルカルボジイ
ミド
DCHA:ジシクロヘキシルアミン
HONB:N―ヒドロキシ―5―ノルボルネン
―2,3―ジカルボキシイミド
ONB:N―ヒドロキシ―5―ノルボルネン―
2,3―ジカルボキシイミド・エステル
TFA:トルフルオロ酢酸
DMF:ジメチルホルムアミド
なお、上記アミノ酸の略号は対応するアミノ酸
残基の表示にもそのまま用いられ、アミノ酸また
はその残基を上記略号で表示する場合、グリシン
以外はL―体を意味するものとする。 Ala: Alanine Arg: Arginine Asn: Asparagine Asp: Aspartic acid Cys: Cysteine Clu: Glutamic acid Gly: Glycine His: Histidine Ile: Isoleucine Pro: Proline Ser: Serine Thr: Threonine Trp: Tryptophan Tyr: Tyrosine Boc: t-Butoxycarbonyl Aoc :Amyloxycarbonyl Bu t :t-Butyl Z:Benzyloxycarbonyl Me: Methyl Bzl: Benzyl Bzl(Cl): p-chlorobenzyl MBzl: p-methoxybenzyl Tos: Tosyl DCC: N,N'-dicyclohexylcarbodiimide DCHA: Dicyclohexylamine HONB: N-hydroxy-5-norbornene-2,3-dicarboximide ONB: N-hydroxy-5-norbornene
2,3-dicarboximide ester TFA: trifluoroacetic acid DMF: dimethylformamide The above amino acid abbreviations are also used as they are to indicate the corresponding amino acid residues, and when an amino acid or its residue is indicated by the above abbreviations, Other than glycine shall mean L-form.
本発明のS―ポリプレニルペプチドの製造原料
であるシステイン含有ペプチド類は該当する保護
ペプチドから保護基を除去することによつて製造
され、保護ペプチドは自体公知の方法によつて製
造される。それら公知の方法については、“The
Peptides”第1巻(1966年)、SchroderとLubke
著、Academic Press、New York、U.S.A、
“ペプチド合成”泉屋ら著、丸善株式会社(1975
年)、または日本生化学会編、生化学実験講座1、
“タンパク質の化学、化学修飾とペプチド合成”
東京化学同人(1977年)などの文献に詳細に説明
されている。 Cysteine-containing peptides, which are raw materials for producing the S-polyprenyl peptide of the present invention, are produced by removing the protecting group from the corresponding protected peptide, and the protected peptide is produced by a method known per se. For information on these known methods, see “The
Peptides” Volume 1 (1966), Schroder and Lubke
Author, Academic Press, New York, USA;
“Peptide Synthesis” by Izumiya et al., Maruzen Co., Ltd. (1975)
2007), or Biochemical Experiment Course 1, edited by the Japanese Biochemical Society,
“Protein chemistry, chemical modification and peptide synthesis”
It is explained in detail in literature such as Tokyo Kagaku Dojin (1977).
以下簡単に原料ペプチドの製造方法について述
べると、まず目的とするポリペプチドを構成しう
る部分アミノ酸またはそのペプチドとその残部を
構成しうる化合物を公知のペプチド合成手段によ
つて縮合させる。縮合手段としては、たとえばア
ジド法、クロライド法、酸無水物法、混酸無水物
法、DCC法、活性エステル法、ウツドワード試
薬Kを用いる方法、カルボジイミダゾール法、酸
化還元法、DCC―アデイテイブ法(HONB、1
―ヒドロオキシベンゾトリアゾール、N―ヒドロ
オキシスクシンイミド等をアデイテイブとして使
用する)などが挙げられる。本縮合反応を行なう
前に、それ自体公知の手段により原料の反応に関
与しないカルボキシル基、アミノ基を保護した
り、水酸基、チオール基を保護して置くことが好
ましいが、保護手段としてはカルボキシル基は第
三級アルキルアミン塩(例えば、トリエチルアミ
ン、N―メチルモルホリン等)や金属塩(例え
ば、ナトリウム、カリウム、リチウム塩等)とし
て保護してもよく、またエステル(例、メチル、
エチル、ベンジル、p―クロルベンジル、t―ブ
チル、t―アミル等のエステル)として保護して
もよい。アミノ基の保護基としてはベンジルオキ
シカルボニル、t―ブトキシカルボニル、イソボ
ルニルオキシカルボニル基等が、ヒスチジンのイ
ミダゾール基の保護基としては、たとえばベンジ
ル、トシル、2,4―ジニトロフエニル、t―ブ
チルオキシカルボニル、カルボベンゾキシル基等
があげられる。アルギニンのグアニジノ基の保護
基としては、たとえば、ニトロ、トシル、カルボ
ベンゾキシル、イソボルニルオキシカルボニル、
アダマンチルオキシカルボニル基等が例示され
る。またチロシン、セリンの水酸基の保護手段と
してはベンジル、t―ブチル、t―アミル等を保
護基とするエーテル等が、チオールの保護手段と
してはベンジル、p―メトキシベンジル、p―メ
チルベンジルやt―ブチル等を保護基とするチオ
エーテル等が例示される。 Briefly describing the method for producing the raw peptide below, first, a partial amino acid that can constitute the target polypeptide or the peptide and a compound that can constitute the remainder thereof are condensed by known peptide synthesis means. Condensation methods include, for example, the azide method, chloride method, acid anhydride method, mixed acid anhydride method, DCC method, active ester method, method using Woodward's reagent K, carbodiimidazole method, redox method, DCC-additive method ( HONB, 1
- Hydroxybenzotriazole, N-hydroxysuccinimide, etc. are used as additives). Before carrying out the main condensation reaction, it is preferable to protect carboxyl groups and amino groups that do not participate in the reaction of the raw materials by means known per se, or to protect hydroxyl groups and thiol groups. may be protected as tertiary alkylamine salts (e.g., triethylamine, N-methylmorpholine, etc.) or metal salts (e.g., sodium, potassium, lithium salts, etc.), or as esters (e.g., methyl,
It may be protected as esters such as ethyl, benzyl, p-chlorobenzyl, t-butyl, t-amyl, etc.). Protective groups for amino groups include benzyloxycarbonyl, t-butoxycarbonyl, isobornyloxycarbonyl groups, etc. Protective groups for imidazole groups of histidine include benzyl, tosyl, 2,4-dinitrophenyl, t-butyloxy, etc. Examples include carbonyl and carbobenzoxyl groups. Protecting groups for the guanidino group of arginine include, for example, nitro, tosyl, carbobenzoxyl, isobornyloxycarbonyl,
Examples include an adamantyloxycarbonyl group. In addition, as means for protecting the hydroxyl groups of tyrosine and serine, ethers with benzyl, t-butyl, t-amyl, etc. are used as protecting groups, and as means for protecting thiols, benzyl, p-methoxybenzyl, p-methylbenzyl, t- Examples include thioethers having butyl as a protecting group.
ペプチド縮合反応は通常用いられる溶媒中で適
宜行うことができ、かかる溶媒としては、たとえ
ば無水または含水のジメチルホルムアミド、ジメ
チルスルホキシド、ピリジン、クロロホルム、ジ
オキサン、ジクロルメタン、テトラヒドロフラ
ン、酢酸エチルあるいはこれらの適宜の混合物が
使用される。反応は一般に−20℃〜+60℃程度の
範囲の温度で行われる。また本発明における原料
化合物はいわゆる固相合成法によつても容易に製
造することができる。 The peptide condensation reaction can be appropriately carried out in a commonly used solvent, such as anhydrous or hydrous dimethylformamide, dimethyl sulfoxide, pyridine, chloroform, dioxane, dichloromethane, tetrahydrofuran, ethyl acetate, or an appropriate mixture thereof. is used. The reaction is generally carried out at a temperature in the range of about -20°C to +60°C. Further, the raw material compounds in the present invention can also be easily produced by a so-called solid phase synthesis method.
このようにして得られた保護されたシステイン
含有ペプチドは、保護基を脱離してチオール・ペ
プチドとして反応に供する。保護基の脱離には、
硫黄の存在のため接触還元は好ましくなく、たと
えばフツ化水素、メタンスルホン酸、トリフルオ
ロメタンスルホン酸などによる酸分解反応による
方法が好ましい。これらの反応は一般にアニソー
ルの存在下−20℃から+40℃程度の温度で行われ
る。この様にして製造された原料ペプチドは、反
応終了後、自体公知のペプチドの分離手段、たと
えば分配、抽出、再沈殿、カラムクロマトグラフ
イーなどによつて精製することができる。 The protected cysteine-containing peptide thus obtained is subjected to a reaction as a thiol peptide by removing the protecting group. For removal of protecting group,
Catalytic reduction is not preferred due to the presence of sulfur, and a method using an acid decomposition reaction using, for example, hydrogen fluoride, methanesulfonic acid, trifluoromethanesulfonic acid, etc. is preferred. These reactions are generally carried out in the presence of anisole at temperatures of about -20°C to +40°C. After the reaction, the raw peptide produced in this manner can be purified by known peptide separation means such as partitioning, extraction, reprecipitation, column chromatography, and the like.
さて、本発明のシステイン含有ペプチドの―
SH基にポリプレニル基を導入する方法は、原料
のシステイン含有ペプチドを例えば含水ジメチル
ホルムアミドに溶解し、酸化マグネシウム等を触
媒としてハロゲン化ポリプレニルを反応せしめる
ことによつて行われる。 Now, the cysteine-containing peptide of the present invention...
A method for introducing a polyprenyl group into an SH group is carried out by dissolving the cysteine-containing peptide as a raw material in, for example, hydrous dimethylformamide and reacting it with a halogenated polyprenyl using magnesium oxide or the like as a catalyst.
含水ジメチルホルムアミド溶液は一般に含水量
10〜70容量%、好ましくは30〜60容量%であり、
酸化マグネシウム量はペプチドに対しモル比で1
〜10当量、好ましくは2〜4当量を使用する。ま
たハロゲン化ポリプレニルはペプチドに対するモ
ル比で1〜10当量、一般には2〜4当量が好まし
い。反応は一般に−10℃〜60℃、好ましくは0℃
〜30℃で行われ、また反応時間は通常3時間〜12
時間程度が好ましい。 Aqueous dimethylformamide solutions generally have a water content of
10-70% by volume, preferably 30-60% by volume,
The amount of magnesium oxide is 1 molar ratio to the peptide.
~10 equivalents are used, preferably 2 to 4 equivalents. Further, the molar ratio of the halogenated polyprenyl to the peptide is 1 to 10 equivalents, preferably 2 to 4 equivalents. The reaction is generally carried out at -10°C to 60°C, preferably 0°C.
It is carried out at ~30℃, and the reaction time is usually 3 hours to 12
About an hour is preferable.
かくして生成するS―ポリプレニルペプチド
は、自体公知の分離精製手段(例、分配、抽出、
再沈殿、カラムクロマトグラフイー)によつて反
応液から単離することができる。 The S-polyprenyl peptide thus produced can be separated and purified by known separation and purification means (e.g., distribution, extraction,
It can be isolated from the reaction solution by reprecipitation, column chromatography).
本発明の方法によつて製造されるS―ポリプレ
ニルペプチド()は、Rhodosporidium
toruloidesに対し、0.1〜10ng/mlの低濃度で接合
管形成促進作用を示し、強力な酵母性ホルモン作
用を有し、また人体に対し安全で取扱いも容易で
ある。従つて、これらのS―ポリプレニルペプチ
ドは天然より単離された同作用を有するホルモン
より強力な作用を示し、これに基づき酵母の育
種、種の改良等に有用であり、また生化学、分子
生化学研究の試薬としても用いることができる。
一般に本化合物の使用に当つては、本化合物を少
くとも上記記載の活性濃度となるように酵母培養
液に添加すればよく、生化学的試薬としては本化
合物を放射性ヨードや蛍光試薬で標識化して使用
することもできる。 The S-polyprenyl peptide () produced by the method of the present invention is Rhodosporidium
It exhibits a zygotic tube formation promoting effect on toruloides at low concentrations of 0.1 to 10 ng/ml, has a strong yeast sex hormone effect, and is safe for the human body and easy to handle. Therefore, these S-polyprenyl peptides exhibit stronger effects than hormones with the same effect isolated from nature, and based on this, they are useful for yeast breeding, seed improvement, etc., and are also useful for biochemistry and molecular research. It can also be used as a reagent in biochemical research.
Generally, when using this compound, it is sufficient to add this compound to yeast culture solution at least at the active concentration described above, and as a biochemical reagent, this compound may be labeled with radioactive iodine or a fluorescent reagent. It can also be used as
次に参考例および実施例を示すが、ここで、薄
層クロマトグラフイーの展開溶媒系は下記の略号
を使用する。 Next, Reference Examples and Examples are shown, in which the following abbreviations are used for developing solvent systems for thin layer chromatography.
Rf1=クロロホルム:メタノール:酢酸(9:
1:0.5)
Rf2=酢酸エチル:ピリジン:酢酸:水(60:
20:6:10)
Rf3=酢酸エチル:n―ブタノール:酢酸:水
(1:1:1:1)
Rf4=n―ブタノール:ピリジン:酢酸:
水(30:20:6:24)
別に記載のない場合Rfは、メルクシリカゲル
プレート 60F254による。Rf 1 = chloroform: methanol: acetic acid (9:
1:0.5) Rf 2 = ethyl acetate: pyridine: acetic acid: water (60:
20:6:10) Rf 3 = ethyl acetate: n-butanol: acetic acid: water (1:1:1:1) Rf 4 = n-butanol: pyridine: acetic acid:
Water (30:20:6:24) Unless otherwise specified, Rf is based on Merck silica gel plate 60F 254 .
参考例 1
1)原料の合成
a)
20.5gとトリエチルアミン9mlをDMF200mlに
溶かして氷冷する。これに臭化ベンジル7.2ml
をDMF35mlに溶解した溶液を滴下し、徐々に
室温にもどしながらかきまぜる。16時間後、析
出した不溶物をろ去し、ろ液の溶媒を減圧留去
する。残留物を酢酸エチル400mlに溶かし、4
%―炭酸ナトリウム水と水で洗い、無水硫酸ナ
トリウムで乾燥する。酢酸エチルを留去し、残
留物にエーテルを加えると結晶となる。ろ取し
てエーテルと石油エーテルから再結晶する。Reference example 1 1) Synthesis of raw materials a) Dissolve 20.5 g and 9 ml of triethylamine in 200 ml of DMF and cool on ice. Add this to 7.2ml of benzyl bromide.
Add dropwise a solution of DMF (35 ml) and stir while gradually returning to room temperature. After 16 hours, the precipitated insoluble matter was filtered off, and the solvent of the filtrate was distilled off under reduced pressure. Dissolve the residue in 400 ml of ethyl acetate,
% - Wash with sodium carbonate and water and dry with anhydrous sodium sulfate. Ethyl acetate is distilled off and ether is added to the residue to form crystals. It is filtered and recrystallized from ether and petroleum ether.
収量16.1g、融点61―64℃、[α]21 D―45.8゜
(c 0.53、メタノール)
元素分析 C23H29O5NS:計算値 C
64.01;H 6.77;N 3.25;S 7.43.分析値
C 64.10;H 6.70;N 3.20;S 7.61
b)
7gをTFA35mlに溶解して室温で5分間かき
まぜる。減圧下にTFAを留去し残留物に少量
のエーテルと石油エーテルを加え油状の析出物
とし、溶媒をのぞいて酢酸エチル 50mlに溶解
し、トリエチルアミン2.3mlで中和する。この
溶液にBoc―Gly―ONB 6gを加え12時間か
きまぜる。反応液を0.2N―塩酸、4%―炭酸
水素ナトリウム水と水で洗い無水硫酸ナトリウ
ムで乾燥したのち溶媒を減圧留去すると油状の
残留物が残る。 Yield 16.1g, melting point 61-64℃, [α] 21 D -45.8゜ (c 0.53, methanol) Elemental analysis C 23 H 29 O 5 NS: Calculated value C
64.01; H 6.77; N 3.25; S 7.43.Analysis value
C 64.10; H 6.70; N 3.20; S 7.61 b) Dissolve 7 g in 35 ml of TFA and stir at room temperature for 5 minutes. TFA is distilled off under reduced pressure, and a small amount of ether and petroleum ether are added to the residue to obtain an oily precipitate.The solvent is removed, dissolved in 50 ml of ethyl acetate, and neutralized with 2.3 ml of triethylamine. Add 6 g of Boc-Gly-ONB to this solution and stir for 12 hours. The reaction solution was washed with 0.2N hydrochloric acid, 4% sodium bicarbonate and water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure, leaving an oily residue.
収量6.7g、Rf1 0.7
c)
6.7gをTFA32.5mlに溶解して室温で10分間か
きまぜる。6.4N―塩酸/ジオキサン溶液2.5ml
を加えて溶媒を減圧留去し残留物を少量のエー
テルを含む石油エーテルで洗いDMF50mlに溶
解する。氷冷してトリエチルアミン2.75mlを加
え、析出するトリエチルアミン塩酸塩をろ去す
る。ろ液をBoc―Asn―OH 3.18gと
HONB3.7gを加え−5℃に冷却したのち
DCC3.11gを加えて撹拌する。約16時間かきま
ぜ、不溶析出物をろ去し、ろ液を減圧乾固す
る。残留物を酢酸エチル300mlに溶解し0.2N―
塩酸、4%―炭酸水素ナトリウム水、および水
で洗つて無水硫酸ナトリウムで乾燥する。溶媒
を減圧留去し、析出する固体をエーテルでろ取
する。 Yield 6.7g, Rf 1 0.7c) Dissolve 6.7g in 32.5ml of TFA and stir at room temperature for 10 minutes. 6.4N-hydrochloric acid/dioxane solution 2.5ml
The solvent is distilled off under reduced pressure, and the residue is washed with petroleum ether containing a small amount of ether and dissolved in 50 ml of DMF. Cool on ice, add 2.75 ml of triethylamine, and filter off the precipitated triethylamine hydrochloride. Add the filtrate to 3.18g of Boc-Asn-OH.
After adding 3.7g of HONB and cooling to -5℃
Add 3.11 g of DCC and stir. Stir for about 16 hours, filter off the insoluble precipitate, and dry the filtrate under reduced pressure. Dissolve the residue in 300ml of ethyl acetate and add 0.2N-
Wash with hydrochloric acid, 4% aqueous sodium bicarbonate, and water, and dry over anhydrous sodium sulfate. The solvent is distilled off under reduced pressure, and the precipitated solid is filtered with ether.
収量5.7g、融点121−123℃、[α]23 D−39.8゜
(c 0.54、メタノール)
元素分析C29H38O8N4S:計算値C 57.79;
H 6.36;N 9.30;S 5.32、計算値C
58.11;H 6.49;N 9.12;S 5.15
d)
5.42gをTFA30mlに溶かし室温で20分間か
きまぜ、減圧でTFAを留去し、残留物に6.4N
―塩酸/ジオキサン1.5mlを加えてかきまぜた
のちエーテルを加えて生ずる沈殿をろ取する。
これをDMF50mlに溶かしトリエチルアミン
0.94mlを冷却下に加えて中和し析出するトリエ
チルアミン塩酸塩をろ去する。ろ液に
2.96gとHONB 2.41gを加え−5℃に冷却し
DCC1.66gを加える。室温で16時間かきまぜて
析出物をろ去し、溶媒を留去する。残留物を酢
酸エチル300mlに抽出し、0.2N―塩酸、4%―
炭酸水素ナトリウム水および水で洗い無水硫酸
ナトリウムで乾燥する。溶媒を留去し、残留物
をエーテルで粉末としてろ取する。これをアセ
トニトリルとエーテルで再沈殿する。 Yield 5.7 g, melting point 121-123°C, [α] 23 D -39.8° (c 0.54, methanol) Elemental analysis C 29 H 38 O 8 N 4 S: Calculated value C 57.79;
H 6.36; N 9.30; S 5.32, calculated value C
58.11; H 6.49; N 9.12; S 5.15 d) Dissolve 5.42 g in 30 ml of TFA and stir at room temperature for 20 minutes. TFA is distilled off under reduced pressure to give a residue of 6.4 N.
- Add 1.5 ml of hydrochloric acid/dioxane and stir, then add ether and filter the resulting precipitate.
Dissolve this in 50ml of DMF and use triethylamine.
Add 0.94 ml under cooling to neutralize and filter off the precipitated triethylamine hydrochloride. to the filtrate Add 2.96g and 2.41g of HONB and cool to -5℃.
Add 1.66g of DCC. Stir at room temperature for 16 hours, filter off the precipitate, and evaporate the solvent. The residue was extracted into 300 ml of ethyl acetate and diluted with 0.2N hydrochloric acid, 4%.
Wash with sodium bicarbonate and water and dry with anhydrous sodium sulfate. The solvent was distilled off, and the residue was filtered as a powder with ether. This is reprecipitated with acetonitrile and ether.
収量5.52g、融点70℃(分解)、[α]23 D−
30.3゜(c0.535、メタノール)、
Rf10.41
e)
5.1gをTFA35mlに溶かし室温で15分間ふりま
ぜたのち減圧乾固し6.4N―塩酸/ジオキサン
1.6mlを加えてさらにエーテルを加えて沈殿と
してろ取する。これをDMF40mlに溶かしトリ
エチルアミン0.78mlを加えて中和し、析出する
トリエチルアミン塩酸塩をろ去する。ろ液に
Boc―Thr―OH1.27gとHONB1.25gで合成
したBoc―Thr―ONBのジオキサン溶液を加
えて16時間かきまぜる。反応終了後溶媒を留去
し、残留物を酢酸エチル500mlに溶かし、0.2N
―塩酸、4%―炭酸水素ナトリウム水および水
で洗い、無水硫酸ナトリウムで乾燥して溶媒を
留去する。残留物に少量の酢酸エチルを加えて
ガラス棒でこするとゲル状結晶となる。これを
エーテルを加えてろ取する。 Yield 5.52g, melting point 70℃ (decomposition), [α] 23 D −
30.3゜(c0.535, methanol), Rf 1 0.41 e) Dissolve 5.1g in 35ml of TFA, stir at room temperature for 15 minutes, and dry under reduced pressure to form 6.4N-hydrochloric acid/dioxane.
Add 1.6 ml and further ether to form a precipitate, which is collected by filtration. Dissolve this in 40 ml of DMF, add 0.78 ml of triethylamine to neutralize it, and filter off the precipitated triethylamine hydrochloride. to the filtrate
Add a dioxane solution of Boc-Thr-ONB synthesized with 1.27 g of Boc-Thr-OH and 1.25 g of HONB and stir for 16 hours. After the reaction, the solvent was distilled off, the residue was dissolved in 500ml of ethyl acetate, and diluted with 0.2N
Wash with hydrochloric acid, 4% sodium bicarbonate and water, dry over anhydrous sodium sulfate and evaporate the solvent. Add a small amount of ethyl acetate to the residue and rub it with a glass rod to form gel-like crystals. Add ether and filter this.
収量5.42g、融点80−80℃(分解)、
[α]23 D −33.0゜(c 0.52、メタノール)、
Rf1 0.20
f)
4.07gをTFA25mlに溶解し、室温に15分間放
置したのち、減圧でTFAを留去し残留物にエ
ーテルを加えてろ取する。これをアセトニトリ
ル3mmに溶かし、トリエチルアミン0.8mlを加
えて中和し、エーテルを加えて沈殿とする。上
澄のエーテルを除いて沈殿をDMFに溶解し氷
冷する、これにBoc―Trp―OH 1.28gと
HONB 907mgから合成したBoc―Trp―ONB
のジオキサン溶液を加えて室温で16時間かきま
ぜる。反応終了後溶媒を減圧留去し、残留物を
酢酸エチル500mlに抽出し、0.2N―塩酸、4%
―炭酸水素ナトリウム水および水で洗い無水硫
酸ナトリウムで乾燥する。溶媒を留去し、残留
物に少量の酢酸エチルを加えるとゲル状物とな
る。これを酢酸エチルとエーテルの混合溶媒で
ろ取する。ろ取した沈殿を酢酸エチルに懸濁
し、沸点まで加温し冷却後ろ取する。 Yield 5.42 g, melting point 80-80°C (decomposition), [α] 23 D -33.0° (c 0.52, methanol), Rf 1 0.20 f) Dissolve 4.07 g in 25 ml of TFA and leave at room temperature for 15 minutes. TFA is distilled off under reduced pressure, ether is added to the residue, and the solution is filtered. Dissolve this in 3 mm of acetonitrile, add 0.8 ml of triethylamine to neutralize it, and add ether to precipitate. Remove the supernatant ether, dissolve the precipitate in DMF, cool on ice, and add 1.28 g of Boc-Trp-OH to this.
Boc-Trp-ONB synthesized from 907mg of HONB
Add dioxane solution and stir at room temperature for 16 hours. After the reaction was completed, the solvent was distilled off under reduced pressure, and the residue was extracted with 500 ml of ethyl acetate.
- Wash with sodium bicarbonate and water and dry with anhydrous sodium sulfate. The solvent is distilled off and a small amount of ethyl acetate is added to the residue to form a gel. This is filtered using a mixed solvent of ethyl acetate and ether. The precipitate collected by filtration is suspended in ethyl acetate, heated to boiling point, cooled, and collected.
収量3.55g、融点120℃(分解)、[α]24 D−
25.8゜(c 0.585、メタノール)、
Rf1 0.18
g)
3.3gを20%―1,2―エタンジチオールを含
有するジオキサン6.5mlに溶かし、6.4N―塩
酸/ジオキサン13mlを加えて室温に35分間放置
する。溶媒を留去し、残留物にエーテルを加え
て粉末としてろ取する。これをDMF10mlに溶
かし、トリエチルアミン0.4mlを加えて中和し
析出するトリエチルアミン塩酸塩をろ去する。
ろ液にBoc―Ser―OH 621mgとHONB 990mg
とを加え氷冷下にDCC749mgを加えてかきまぜ
る。室温で16時間かきまぜたのち、不溶物をろ
去する。溶媒を減圧で留去し、残留物にエーテ
ルを加えて粉末としろ取する。これを酢酸エチ
ル:ピリジン:酢酸:水(120:10:3:5)
の溶液で充填したシリカゲルカラム(5.5×
12.5cm)に流入し、同じ溶媒で溶出する、1490
〜2785mlの溶出部分を集めて濃縮し、エーテル
を加え、生ずる粉末をろ取する。 Yield 3.55g, melting point 120℃ (decomposition), [α] 24 D −
25.8° (c 0.585, methanol), Rf 1 0.18 g) Dissolve 3.3 g in 6.5 ml of dioxane containing 20%-1,2-ethanedithiol, add 13 ml of 6.4N-hydrochloric acid/dioxane, and leave at room temperature for 35 minutes. The solvent was distilled off, ether was added to the residue, and the powder was collected by filtration. Dissolve this in 10 ml of DMF, neutralize by adding 0.4 ml of triethylamine, and filter off the precipitated triethylamine hydrochloride.
Boc-Ser-OH 621mg and HONB 990mg in filtrate
Add 749mg of DCC and stir while cooling on ice. After stirring at room temperature for 16 hours, insoluble matter was filtered off. The solvent was distilled off under reduced pressure, and ether was added to the residue, which was filtered as a powder. Add this to ethyl acetate:pyridine:acetic acid:water (120:10:3:5)
Silica gel column (5.5×
12.5cm) and elutes with the same solvent, 1490
The ~2785 ml eluate is collected and concentrated, ether is added and the resulting powder is filtered off.
収量1.9g、融点150−153℃(分解)、
[α]25 D −28.2゜(c 0.34、メタノール)
元素分析 C60H78O16N12S2:計算値
C 55.97;H 6.11;N 13.06;S 4.98、
分析値C 55.57;H 6.27;N 12.67;S
4.77
h) Boc―Tyr―Pro―OHの製造:H―Pro―
OH 4.4gを含水ジオキサン80mlに溶解しトリ
エチルアミン4.75mlを加え氷冷する。この溶液
にBoc―Tyr―ONB 11.1gを加えてはげしく
かきまぜる。溶媒を留去して、4%炭酸水素ナ
トリウム水80mlに溶解しエーテル50mlで洗い、
氷冷して0.2N―塩酸でPH2とし析出する油状
物を酢酸エチル100mlに抽出する。酢酸エチル
層を水洗し、無水硫酸ナトリウムで乾燥して溶
媒を留去する。析出した結晶にエーテルを加え
てろ取する。 Yield 1.9g, melting point 150-153℃ (decomposed), [α] 25 D -28.2゜ (c 0.34, methanol) Elemental analysis C 60 H 78 O 16 N 12 S 2 : Calculated value C 55.97; H 6.11; N 13.06 ;S 4.98,
Analysis value C 55.57; H 6.27; N 12.67; S
4.77 h) Production of Boc-Tyr-Pro-OH: H-Pro-
Dissolve 4.4 g of OH in 80 ml of aqueous dioxane, add 4.75 ml of triethylamine, and cool on ice. Add 11.1 g of Boc-Tyr-ONB to this solution and stir vigorously. The solvent was distilled off, the solution was dissolved in 80 ml of 4% sodium bicarbonate water, and washed with 50 ml of ether.
Cool on ice, adjust the pH to 2 with 0.2N hydrochloric acid, and extract the precipitated oil into 100 ml of ethyl acetate. The ethyl acetate layer is washed with water, dried over anhydrous sodium sulfate, and the solvent is distilled off. Add ether to the precipitated crystals and collect by filtration.
収量4.3g、融点123−126℃(分解)、
[α]22.5 D −23.6゜(c 0.525、メタノール)、
元素分析 C19H26O6N2:計算値 C
60.30;H 6.93;N 7.40.分析値 C
60.15;H 6.80;N 7.30.
i)
の製造:H―Ile―OBzl p―トルエンスルホ
ン酸塩14.2gを酢酸エチル400mlに懸濁し、飽
和炭酸ナトリウム水で洗い、さらに水洗して無
水硫酸ナトリウムで乾燥し、溶媒を減圧留去す
る。次に
15.6gを酢酸エチル300mlに懸濁し0.2N―硫酸
でDCHAを抽出除去する、さらに水洗後、無
水硫酸ナトリウムで乾燥したのち溶媒を減圧で
留去する。両者をテトラヒドロフランと酢酸エ
チル(1:1)の混合溶媒140mlに溶解し、
HONB 8.1gを加え氷冷してDCC7.44gを加え
かきまぜる。12時間室温でかきまぜ、析出物を
ろ去し、溶媒を留去ののち残留物を酢酸エチル
300mlに溶解する。これをIN―塩酸、4%―炭
酸水素ナトリウム水、および水で洗い無水硫酸
ナトリウムで乾燥する。溶媒を留去して室温に
放置すると結晶化するのでこれに石油ベンジン
を加えてろ取する。 Yield 4.3g, melting point 123-126℃ (decomposition), [α] 22.5 D -23.6゜ (c 0.525, methanol), elemental analysis C 19 H 26 O 6 N 2 : Calculated value C
60.30; H 6.93; N 7.40. Analysis value C
60.15; H 6.80; N 7.30. i) Production: 14.2 g of H-Ile-OBzl p-toluenesulfonate was suspended in 400 ml of ethyl acetate, washed with saturated sodium carbonate water, further washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. next 15.6 g was suspended in 300 ml of ethyl acetate, and DCHA was extracted and removed with 0.2N sulfuric acid. After further washing with water and drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. Both were dissolved in 140 ml of a mixed solvent of tetrahydrofuran and ethyl acetate (1:1),
Add 8.1g of HONB, cool on ice, add 7.44g of DCC, and stir. Stir at room temperature for 12 hours, filter off the precipitate, distill off the solvent, and dissolve the residue in ethyl acetate.
Dissolve in 300ml. This is washed with IN-hydrochloric acid, 4% aqueous sodium bicarbonate, and water, and dried over anhydrous sodium sulfate. When the solvent is distilled off and the mixture is left at room temperature, it crystallizes, and petroleum benzine is added thereto and the mixture is filtered.
収量13g、融点65―68℃、[α]23 D−24.5゜(c
0.60、メタノール)、Rf10.92
j)
5.4gをN―塩酸10mlとともにメタノールに溶
解し、パラジウム黒1gを加え水素を通じて還
元する。パラジウム黒をろ別し、メタノールを
減圧留去し、残留物をDMF100mlに溶解し、氷
冷下にトリエチルアミン2.8mlを加える。別に
Boc―Tyr―Pro―OH 3.78gとHONB 2.16g
を酢酸エチルとジオキサン(1:1)の混合溶
媒100mlに溶解しDCC2.27gを加えて室温で6
時間かきまぜる。析出物をろ去し、このろ液を
先のDMF溶液に加え、16時間かきまぜる。反
応終了後、溶媒を減圧留去し、炭酸水素ナトリ
ウム2.5gを含む水200mlに抽出してエーテルで
洗う。水層を氷冷し、N―塩酸35mlで酸性とし
析出する油状物を酢酸エチル200mlで2回抽出
する。酢酸エチル層を合し水洗ののち、無水硫
酸ナトリウムで乾燥する。酢酸エチルを減圧留
去し、残留物をエーテルで粉末としてろ取す
る。これをクロロホルム:メタノール:水
(107:4:2)の混合溶媒でシリカゲルカラム
(5.5×12.5cm)に付し同じ溶媒系で溶出し680
−980mlの溶出部分を集めて溶媒を留去し、残
留物をエーテルで粉末としてろ取する。 Yield 13g, melting point 65-68℃, [α] 23D -24.5゜(c
0.60, methanol), Rf 1 0.92 j) Dissolve 5.4 g in methanol with 10 ml of N-hydrochloric acid, add 1 g of palladium black, and reduce through hydrogen. Palladium black is filtered off, methanol is distilled off under reduced pressure, the residue is dissolved in 100 ml of DMF, and 2.8 ml of triethylamine is added under ice cooling. separately
Boc―Tyr―Pro―OH 3.78g and HONB 2.16g
was dissolved in 100 ml of a mixed solvent of ethyl acetate and dioxane (1:1), 2.27 g of DCC was added, and the solution was dissolved at room temperature.
Stir the time. Filter off the precipitate, add this filtrate to the above DMF solution, and stir for 16 hours. After the reaction is complete, the solvent is distilled off under reduced pressure, extracted into 200 ml of water containing 2.5 g of sodium hydrogen carbonate, and washed with ether. The aqueous layer is cooled with ice, acidified with 35 ml of N-hydrochloric acid, and the precipitated oil is extracted twice with 200 ml of ethyl acetate. The ethyl acetate layers are combined, washed with water, and then dried over anhydrous sodium sulfate. Ethyl acetate was distilled off under reduced pressure, and the residue was filtered as a powder with ether. This was applied to a silica gel column (5.5 x 12.5 cm) using a mixed solvent of chloroform:methanol:water (107:4:2) and eluted with the same solvent system to obtain 680
-980 ml of the eluate is collected, the solvent is distilled off, and the residue is filtered off as a powder with ether.
収量3.45g、融点115−119℃(分解)、[α]
23 D−40.2゜(c 0.465、メタノール)
元素分析 C34H52O10N4:計算値 C
60.34;H 7.74;N 8.28、分析値 C
60.22;H 8.02;N 7.82、
k)
644mgをDMF0.5mlとジオキサン2mlに溶解し、
1,2―エタンジオール0.3mlと6.4N―塩酸/
ジオキサン6mlを加え室温で30分間ふりまぜ
る。溶媒を減圧で留去し、残留物にエーテルを
加え粉末としてろ取する。これをDMF5mlに溶
解しトリエチルアミン0.3mlを加えて中和する。
析出するトリエチルアミン塩酸塩はろ去し、ろ
液に
406mgとHONB 360mgを加え−10〜−5℃に冷
却する。DCC 206mgを加えて16時間かきまぜ
る。析出した不溶物をろ去し溶媒を留去し、残
留物をアセトニトリルと酢酸エチルとで粉末と
してろ取する。 Yield 3.45g, melting point 115-119℃ (decomposition), [α]
23 D −40.2゜(c 0.465, methanol) Elemental analysis C 34 H 52 O 10 N 4 : Calculated value C
60.34; H 7.74; N 8.28, analysis value C
60.22; H 8.02; N 7.82, k) Dissolve 644mg in DMF 0.5ml and dioxane 2ml,
1,2-ethanediol 0.3ml and 6.4N-hydrochloric acid/
Add 6 ml of dioxane and stir at room temperature for 30 minutes. The solvent was distilled off under reduced pressure, ether was added to the residue, and the powder was collected by filtration. Dissolve this in 5 ml of DMF and neutralize by adding 0.3 ml of triethylamine.
The precipitated triethylamine hydrochloride is filtered off and added to the filtrate. Add 406 mg and 360 mg of HONB and cool to -10 to -5°C. Add 206 mg of DCC and stir for 16 hours. The precipitated insoluble matter is removed by filtration, the solvent is distilled off, and the residue is filtered as a powder using acetonitrile and ethyl acetate.
収量650mg、融点100−105℃(分解)、[α]25 D
−26.6゜(c 0.365、メタノール)、
元素分析 C89H120O23N16S2・2H2O:
計算値 C56.79;H6.64;N11.91;S3.41.
分析値 C56.23;H6.67;N11.67;S3.90.
アミノ酸分析、分析値(理論値):Arg 0.99
(1)、Asp 1.03(1)、Thr 0.98(1)、Ser 0.92(1)、
Glu 0.87(1)、、Pro 1.09(1)、Glx 1.0(1)、Cys
0.37(1)、Ile 0.85(1)、Tyr 0.68(1)、平均回収率
72%
) H―Tyr―Pro―Glu―Ile―SerTrp―Thr
―Arg―Asn―Gly―Cys―OHの製造:
554mgをアニソール1.6ml共存下に弗化水素20ml
に溶解し、0℃で60分間かきまぜる。弗化水素を
減圧留去し残留物を水10mlに抽出しエーテル5ml
で洗う。水層をアンバーライトIRA―410(酢酸
型)の樹脂カラム(1×5cm)に通し、水洗い、
全通過液を合せて凍結乾燥し405mgを得る。これ
をセフアデツクスLH―20(2.4×107cm)のカラム
に付し、0.1N―酢酸で溶出し237−281mlの溶出
液を集め凍結乾燥して106mgのSHペプチドを得
る。 Yield 650mg, melting point 100-105℃ (decomposition), [α] 25 D
−26.6° (c 0.365, methanol), elemental analysis C 89 H 120 O 23 N 16 S 2・2H 2 O: Calculated value C56.79; H6.64; N11.91; S3.41. Analysis value C56.23 ;H6.67;N11.67;S3.90. Amino acid analysis, analysis value (theoretical value): Arg 0.99
(1), Asp 1.03(1), Thr 0.98(1), Ser 0.92(1),
Glu 0.87(1), Pro 1.09(1), Glx 1.0(1), Cys
0.37(1), Ile 0.85(1), Tyr 0.68(1), Average recovery rate
72%) H-Tyr-Pro-Glu-Ile-SerTrp-Thr
-Production of Arg-Asn-Gly-Cys-OH: 554 mg in the presence of 1.6 ml of anisole and 20 ml of hydrogen fluoride
and stir at 0°C for 60 minutes. Hydrogen fluoride was distilled off under reduced pressure, and the residue was extracted with 10 ml of water and 5 ml of ether.
wash with The aqueous layer was passed through a resin column (1 x 5 cm) of Amberlite IRA-410 (acetic acid type), washed with water,
All the flow throughs are combined and lyophilized to give 405 mg. This was applied to a Sephadex LH-20 (2.4 x 107 cm) column, eluted with 0.1N acetic acid, and 237-281 ml of the eluate was collected and lyophilized to obtain 106 mg of SH peptide.
[α]26 D −63.5゜(c 0.60、1N―酢酸)、Rf4
(セルロース)0.64
アミノ酸分析、分析値(理論値):Arg1.14(1)、
Trp0.59(1)、Asp 1.00(1)、Thr 1.00(1)、Ser 0.95
(1)、Glu 0.95(1)、Pro 1.02(1)、Gly 1.00(1)、Cys
0.86(1)、Ile 0.95(1)、Tyr 0.98(1)、平均回収率
79.1%
実施例 1
H―Tyr―Pro―Glu―Ile―Ser―Trp―Thr―
Arg―Asn―Gly―Cys(S―ペンタプレニル)―
OH の製造:H―Tyr―Pro―Glu―Ile―Ser―
Trp―Thr―Arg―Asn―Gly―Cys―OH 40mgを
MgO 6mgとともに70%含水DMF3mlに溶かし、
臭化ペンタプレニル(トランス体)のイソプロピ
ルエーテル溶液0.5ml(0.05mmol)を滴下し16時
間かきまぜる。溶媒を減圧留去し85%n―ブタノ
ール 水溶液0.5mlに溶かし、セフアデツクスLH
―20のカラム(2.3×28.5cm)に展開する。40〜
56mlの区分を集め濃縮し、再び同じカラムに展開
し、目的区分を集め溶媒を留去して10mgの目的物
を得る。 [α] 26 D −63.5° (c 0.60, 1N-acetic acid), Rf 4
(Cellulose) 0.64 Amino acid analysis, analysis value (theoretical value): Arg1.14(1),
Trp0.59(1), Asp 1.00(1), Thr 1.00(1), Ser 0.95
(1), Glu 0.95(1), Pro 1.02(1), Gly 1.00(1), Cys
0.86(1), Ile 0.95(1), Tyr 0.98(1), Average recovery rate
79.1% Example 1 H-Tyr-Pro-Glu-Ile-Ser-Trp-Thr-
Arg-Asn-Gly-Cys (S-pentaprenyl)-
Production of OH: H-Tyr-Pro-Glu-Ile-Ser-
Trp―Thr―Arg―Asn―Gly―Cys―OH 40mg
Dissolve in 3 ml of 70% hydrated DMF with 6 mg of MgO,
Add dropwise 0.5 ml (0.05 mmol) of an isopropyl ether solution of pentaprenyl bromide (trans isomer) and stir for 16 hours. The solvent was distilled off under reduced pressure, dissolved in 0.5 ml of 85% n-butanol aqueous solution, and Sephadex LH
- Develop into 20 columns (2.3 x 28.5 cm). 40~
Collect a 56 ml fraction, concentrate it, apply it again to the same column, collect the target fraction, and distill off the solvent to obtain 10 mg of the target product.
Rf3 0.70 Rf3 0.70
Claims (1)
Trp―Thr―Arg―Asn―Gly―で表わされるペプ
チド鎖を示す]で表わされるS―ポリプレニルペ
プチド。[Claims] 1 formula [In the formula, X is H-Tyr-Pro-Glu-Ile-Ser-
An S-polyprenyl peptide represented by a peptide chain represented by Trp-Thr-Arg-Asn-Gly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62128684A JPS6354396A (en) | 1987-05-26 | 1987-05-26 | S-polyprenyl peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62128684A JPS6354396A (en) | 1987-05-26 | 1987-05-26 | S-polyprenyl peptide |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11366379A Division JPS5639055A (en) | 1979-09-04 | 1979-09-04 | S-polyprenylpeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6354396A JPS6354396A (en) | 1988-03-08 |
JPS6360040B2 true JPS6360040B2 (en) | 1988-11-22 |
Family
ID=14990872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62128684A Granted JPS6354396A (en) | 1987-05-26 | 1987-05-26 | S-polyprenyl peptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6354396A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113416231B (en) * | 2021-05-11 | 2022-11-18 | 四川大学 | Sea squirt antioxidant polypeptide and preparation method thereof |
-
1987
- 1987-05-26 JP JP62128684A patent/JPS6354396A/en active Granted
Non-Patent Citations (1)
Title |
---|
AGRIC.BIOL.CHEM=1979 * |
Also Published As
Publication number | Publication date |
---|---|
JPS6354396A (en) | 1988-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1065856A (en) | Derivatives of salmon calcitonin | |
US4271068A (en) | Process for the manufacture of cystine-containing peptides | |
KR910001724B1 (en) | Process for preparation of peptide with psychopharmacological property | |
JP2508755B2 (en) | Peptide attractant and method for producing the same | |
FR2557114A1 (en) | NOVEL DERIVATIVES OF GONADOLIBERIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
JPS6251280B2 (en) | ||
JPS6360040B2 (en) | ||
US6448031B1 (en) | Process for producing LH-RH derivatives | |
JPH0223543B2 (en) | ||
Hase et al. | SYMMETRICAL DISULFIDE BONDS AS S‐PROTECTING GROUPS AND THEIR CLEAVAGE BY DITHIOTHREITOL: SYNTHESIS OF OXYTOCIN WITH HIGH BIOLOGICAL ACTIVITY | |
JPS6225159B2 (en) | ||
YAMASHIRO et al. | Synthesis and properties of human β‐endorphin‐(1–9) and its analogs | |
US4159979A (en) | Protected amino acids or peptides | |
JPS6120560B2 (en) | ||
EP0056274A1 (en) | Indole derivatives and a method for production of peptides | |
JPS6319519B2 (en) | ||
KISO et al. | Solution-phase synthesis of porcine brain natriuretic peptide (pBNP) using S-trimethylacetamido-methylcysteine | |
NOMIZU et al. | Studies on Peptides. CLVII.: Synthesis of a Frog-Skin Peptide, Sauvagine | |
EP0266170A2 (en) | Peptide derivative and its production | |
JPH0134239B2 (en) | ||
HEMMASI et al. | Synthesis of the C-terminal decapeptide of bovine insulin B-chain | |
KR20010024156A (en) | Process for the preparation of calcitonin | |
JPH08333389A (en) | Production of hexapeptide | |
KR20010024155A (en) | Amino acid derivatives | |
JPH0224836B2 (en) |